From: Histology of variants of urothelial carcinoma of the bladder: a Moroccan series of 39 cases
Study population (n = 39) | |
---|---|
Sex, n (%) | |
Male | 36 (92) |
Female | 3 (8) |
Mean age, (years) | 62 |
Tobacco, n (%) | |
Yes | 30 (77) |
No | 9 (23) |
ECOG PS, n (%) | |
0 | 9 (23) |
1 | 17 (43.5) |
≥ 2 | 13 (33.5) |
Hydronephrosis, n (%) | |
Present | 17 (33.5) |
Absent | 22 (56.5) |
Clinical stage T, n (%) | |
T1 | 2 (5) |
T2 | 2 (5) |
T3 | 16 (41) |
T4 | 9 (23) |
Tx | 10 (26) |
Lymph node clinical stage N, n (%) | |
N0 | 18 (46) |
N1 | 6 (15) |
N2 | 5 (13) |
Nx | 10 (26) |
Visceral metastases, n (%) | |
Yes | 9 (23) |
No | 30 (77) |
Treatment received, n (%) | |
TURB alone | 1 (3) |
TURB + systemic chemotherapy | 11 (28) |
TURB + BCG therapy | 9 (23) |
RCP | 14 (36) |
Refusal of radical treatment | 4 (10) |
Mean follow-up, (months) | 18 |